Stem Cell Transplant for Sickle Cell Disease More Cost-Effective Than Gene Therapy

(MedPage Today) -- Non-myeloablative haploidentical allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a more cost-effective strategy compared with gene therapy for treating sickle cell disease (SCD), researchers found.
Their cost...